The importance of β-lactamase resistance in surgical infections

Surgical Infections

Volumn 2, Issue SUPL. 1, 2001, Pages

  Edmiston Jr , Charles E ^a   Hennen, Cindy ^a   Seabrook, Gary R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; IMIPENEM; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; ENTEROBACTER; ENTEROBACTERIACEAE; GRAM NEGATIVE INFECTION; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; PRIORITY JOURNAL; RELAPSE; SPECIES DIFFERENCE; STRAIN DIFFERENCE; SURGICAL INFECTION; TREATMENT FAILURE;

EID: 0035682952     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2001.2.s1-13     Document Type: Article

References (35)

1. Public health focus: Surveillance, prevention and control of nosocomial infections
2. Selected aspects of the socioeconomic impact of nosocomial infections: Morbidity, mortality, cost, and prevention
3. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
4. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System
5. Major trends in the microbial etiology of nosocomial infection
6. Antimicrobial resistance in intensive care units
7. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999
8. Beta-lactamase and bacterial resistance to antibiotics
9. The β-lactamases of gram-negative bacteria and their role in resistance to β-lactam antibiotics
10. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes
11. Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae
12. A review of the mechanisms of action and resistance of antimicrobial agents
13. Resistance mechanisms in Pseudomonas aeruginosa and other non-fermentative gram-negative bacteria
14. An enzyme from bacteria able to destroy penicillin
15. Plasmid-mediated β-lactamases of Gram-negative bacteria: Properties and distribution
16. Vancomycin-resistant enterococci
17. Frequency of plasmid-determined beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae
18. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
19. Epidemiology of extended-spectrum beta-lactamases
20. Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended beta-lactamase-producing Enterobacteriaceae
21. Sulbactam plus ampicillin: Interim review of efficacy and safety for therapeutic and prophylactic use
22. Intravenous sulbactam/ampicillin in the treatment of pediatric infections
23. Antibiotic therapy of intra-abdominal sepsis in the elderly: Experience with ticarcillin and clavulanic acid
24. Effect of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coli
25. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria
26. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors
27. Beta-lactamase types and beta-lactam resistance of Escherichia coli strains with chromosomally mediated ampicillin resistance
28. Microbiologic and pharmacodynamic principles applied to the antimicrobial susceptibility testing of ampicillin/sulbactam
29. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes
30. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli
31. Correlation of in vitro susceptibility results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli
32. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections
33. Epidemiology, resistance, and outcome of Acinetobacter baumanii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam
34. Spread of extended-spectrum beta-lactamase producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value?
35. Survey of blood stream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Program, 1997